Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.49 |
| ▸ | NPY4R | P50391 | 10/20 | 0.46 |
| ▸ | NPY5R | Q15761 | 9/20 | 0.46 |
| ▸ | NPY1R | P25929 | 8/20 | 0.46 |
| ▸ | NPY2R | P49146 | 6/20 | 0.46 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.46 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.46 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.46 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.46 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.46 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.46 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.42 |
| ▸ | RAMP3 | O60896 | 5/20 | 0.41 |
| ▸ | CALCR | P30988 | 5/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30881179 | 0.95 | NPY4R (0.46) | TFPINPY4RNPY5RNPY1RNPY2R | |
| SCHEMBL29886744 | 0.91 | TFPI (0.48) | TFPINPY4RNPY5RNPY1RNPY2R | |
| SCHEMBL30930537 | 0.91 | TFPI (0.47) | TFPINPY4RNPY5RNPY1RNPY2R | |
| SCHEMBL31665996 | 0.90 | NPY4R (0.45) | TFPINPY4RNPY5RNPY1RNPY2R | |
| SCHEMBL31665959 | 0.90 | NMT2 (0.41) | TFPINPY4RNPY5RNPY1RNPY2R | |
| SCHEMBL30881182 | 0.90 | TFPI (0.46) | TFPINPY4RNPY5RNPY1RNPY2R | |
| SCHEMBL31461994 | 0.89 | NPY4R (0.49) | NPY4RNPY5RNPY1RNPY2R | |
| SCHEMBL30432333 | 0.88 | TFPI (0.58) | TFPINPY4RNPY5RNPY1RNPY2R | |
| SCHEMBL30296729 | 0.88 | GRIN2D (0.61) | TFPIGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL30974313 | 0.88 | NMT1 (0.43) | NPY4RNPY5RNPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250381281-A1 | METHODS OF MANUFACTURING PEPTIDE-BASED VACCINES | BARINTHUS BIOTHERAPEUTICS NORTH AMERICA INC (US) | 2025-12-18 | — | — | US | disclosed |
| US-12370255-B2 | Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response | BARINTHUS BIOTHERAPEUTICS NORTH AMERICA, INC. (US) | 2025-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250381281-A1 | METHODS OF MANUFACTURING PEPTIDE-BASED VACCINES | VIP, HM13, SPPL2B | TFPI 1210/4885NPY4R 1087/4885NPY5R 1326/4885 |
| US-12370255-B2 | Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response | MYD88, ICOS, CD4 | TFPI 2280/4885NPY4R 807/4885NPY5R 1074/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.